Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Partek's Pathway Software

Premium

Software vendor Partek this week released Pathway. The tool allows users to study gene-gene and gene-protein relationships with the ability to identify and display significantly affected pathways, search for specific pathways and genes, and color-code them based on their p-values and fold changes.

Additionally, the tool has an interactive pathway browser and links to other online databases. According to Partek, its Pathway tool supports raw data from "all major commercial next-generation sequencing and microarray platforms."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.